drugset / Trial / NCT00690638
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus
Timeline
- Start
- 2008-07
- Primary completion
- 2010-01
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutogliptin | Small molecule | 200 mg | — |
| Subject | Dutogliptin | Small molecule | 400 mg | — |